HERBERT Y. REYNOLDS, M.D.; ARTHUR S. LEVINE, M.D.; ROBERT E. WOOD, Ph.D., M.D.; CHARLES H. ZIERDT, Ph.D.; DAVID C. DALE, M.D.; JAMES E. PENNINGTON, M.D.
Despite the availability of specific antibiotics, Pseudomonas aeruginosa bacteria still cause troublesome infections in patients with a variety of illnesses: extensive thermal injury, leukopenia from antineoplastic chemotherapy and other forms of immunosuppressive treatment, chronic pulmonary disease such as cystic fibrosis, or intravenous narcotic use. The use of antibiotics has improved the prognosis of pseudomonas infections considerably. However, patients with marginal or defective host immunity may need more extensive therapy to master the infection. By evaluating additional modalities of treatment such as granulocyte replacement, improved usage of antibiotics, and active (prophylaxis) or passive antibody administration, the optimal combination may be found.
Learn more about subscription options.
Register Now for a free account.
REYNOLDS HY, LEVINE AS, WOOD RE, ZIERDT CH, DALE DC, PENNINGTON JE. Pseudomonas aeruginosa Infections: Persisting Problems and Current Research to Find New Therapies. Ann Intern Med. 1975;82:819–831. doi: 10.7326/0003-4819-82-6-819
Download citation file:
Published: Ann Intern Med. 1975;82(6):819-831.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only